FierceHealthcareFierceHealthITFierceHealthFinanceHospital Impact   FiercePharmaFierceBiotechFierceSarbox
Syndicate content

dr david news from FierceHealthcare

News

Lawsuits, insurance costs stymie ob-gyns

Would you want your baby to be delivered by a complete stranger? According to an article in the Times-Picayune, that scenario is becoming a reality more quickly than you'd think. The threat of... Read more...

Like peers, raises shrink for Mass. hospital execs

While most Massachusetts hospital execs got raises last year, most were smaller raises than the previous year, mirroring a national trend in compensation for hospital executives. What makes... Read more...

SPOTLIGHT: Physician-marketer gets kudos, criticism


Few physicians throw themselves into sales more enthusiastically than Dr. David Louise Matlock. Matlock, an OB/GYN who says he makes $12 million a year, appears frequently on the E! network, owns stock options in a company making lasers he uses and is marketing a reality TV show starring himself. Some colleagues admire his drive and ingenuity. But his approach, which includes aggressive, hyped-up Web marketing, has taken fire from some members of medical community, who see his practices as ethically questionable. Article

Drug reactions send 700,000 patients to ER each year

According to a report published in the Journal of the American Medical Association, 700,000 Americans go to the ER each year as a result of adverse drug reactions or interactions. Patients over 65 were much more likely to experience these problems because of the greater number of prescription drugs they take. Certain types of drugs are also much more likely to send people to the ER: “three medications--the blood thinner warfarin, the diabetes drug insulin and the heart medicine digoxin--accounted for one-third of drug-related emergency room visits among people over 65,” reports the Los Angeles Times. Experts say the study illuminates the need for the medical community to better monitor which drugs patients are taking and how they might interact. In addition, Dr. David Bates of Brigham and Women's Hospital in Boston says prescribing slightly lower levels of drugs to the elderly could cut down on hospital visits since many elderly patients’ bodies can’t handle high drug doses.

... Read more...

NIH gives $100M to speed research-to-care process

The National Institutes of Health (NIH) announced this week that it has given a dozen academic medical centers a total of $100 million in an initiative intended to help these institutions move discoveries quickly from the lab to the bedside. The twelve universities receiving the grants are now part of a consortium; members are expected to help scientists work together, rather than compete aggressively for dollars, intellectual leadership and prestige as is more the norm in research …

... Read more...

SPOTLIGHT: MD charged with drug distribution


A Kentucky anesthesiologist is facing a federal indictment for writing illegal Oxycontin and hydrocodone prescriptions. Metro Narcotics officers say Dr. David A. Thomas wrote prescriptions for contractors remodeling his house in exchange for free labor and materials. Thomas pleaded not guilty to the charges. Article

FDA officials worried over Ketek

Wouldn't it be nice if the FDA put patient safety first, rather than rubber-stamping drug approvals? Turns out some staffers do, even if they're ignored. Internal FDA emails obtained by The New York Times show a federal drug safety official, Dr. David Graham, urging the withdrawal of the controversial antibiotic Ketek (telithromycin), which has caused liver damage and sometimes death in otherwise healthy patients. "It's as if every principle governing the review and approval of …

... Read more...

Pushing the envelope on evidence-based medicine

Evidence-based medicine guru Dr. David Eddy has been very busy over the last ten years, BusinessWeek reports in this week's cover story. Eddy endured instant "Salmaan Rushdie"-like status when he appeared on the scene 25 years ago, arguing that medicine needs to embrace a burden of scientific proof for new procedures and therapies. Skeptics have always asked if the whole idea isn't more about finding reasons not to pay for new treatments. But there's little doubt that Eddy is here …

... Read more...

Questions surround Brailer's resignation

Does Dr. David Brailer's resignation late last week signify problems ahead for government health IT? Did the health IT czar quit because he was growing tired of the grind of his weekly commute from San Francisco to Washington or out of frustration with the program's direction? Expect the theories to fly fast and furiously this week in the aftermath of the decision. Brailer told the San Francisco Chronicle that he hopes to continue working in health information technology in the …

... Read more...

Brailer leaves HIT post

Dr. David Brailer, who was the national coordinator for health information technology for the past two years, told the Financial Times that he is resigning for "family reasons" and because the national health IT program "is now mature and moving in the right direction." The timing of the announcement, which comes on the same week as the resignation of White House press secretary Scott McClellan and the "demotion" of policy advisor Karl Rove, has led to speculation that the move …

... Read more...

Get more dr david coverage at: